Papers
9
Total Citations
349
H-Index
6
About
Wei Phin Tan is a leading urologic oncologist whose research focuses on advancing surgical techniques for bladder and prostate cancer, particularly through robotic-assisted procedures. His most impactful work centers on comparing robot-assisted radical cystectomy (RARC) with open radical cystectomy (ORC), where his 2023 meta-analysis of randomized controlled trials—cited over 100 times—provided critical evidence on perioperative, oncological, and quality-of-life outcomes. Earlier, his 2016 meta-analysis (82 citations) challenged assumptions about RARC’s superiority, showing no clear benefit over ORC for extracorporeal urinary diversion. Tan also pioneered investigations into lymph node yield during robot-assisted cystectomy (72 citations), demonstrating that adequate dissection is achievable even in early experience. His work on managing the median lobe during robotic prostatectomy and evaluating tumor volume’s impact on surgical outcomes has further shaped clinical practice. With a career spanning over a decade, Tan’s rigorous evidence synthesis has helped define the role of robotics in urologic oncology, guiding surgeons in balancing innovation with proven patient outcomes. His contributions remain essential reading for researchers and clinicians navigating the evolving landscape of minimally invasive cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3The lymph node yield during robot‐assisted radical cystectomy72 citations · 2008
- 4
- 5
- 6
- 7
- 8
- 9